alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
A sialooctaosylceramide having α-Neu5Ac-(2→3)-β-<small>D</small>-Gal-(1→4)-β-<small>D</small>-GlcNAc-(1→3)-[β-<small>D</small>-Gal-(1→4)-β-<small>D</small>-GlcNAc-(1→6)]-β-<small>D</small>-Gal-(1→4)-β-<small>D</small>-GlcNAc-(1→3)-β-<small>D</small>-Gal-(1→4)-β-<small>D</small>-Glc as the sialooctaosyl component.